Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
Identification of the immune suppressive mechanisms active within the tumor microenvironment led to development of immunotherapeutic strategies aiming to reverse the immunosuppression and to enhance the function of tumor-infiltrating lymphocytes. Of those, cancer therapy with antibodies targeting th...
Main Authors: | Dmitriy Zamarin, Jedd D Wolchok |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770516300262 |
Similar Items
-
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
by: Dmitriy Zamarin, et al.
Published: (2017-02-01) -
Correction: Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
by: Qing Zhang, et al.
Published: (2020-11-01) -
Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines
by: Srinivasan Roopa, et al.
Published: (2004-04-01) -
Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
by: Tiffany Y. Ho, et al.
Published: (2021-09-01) -
Oncolytic Viruses for Canine Cancer Treatment
by: Diana Sánchez, et al.
Published: (2018-10-01)